What is Bone Biologics Corp Common Stock's Market Cap?

Bone Biologics Corp Common Stock's Market Cap is $1.5M, based on as-reported figures from SEC (XBRL) filings.

What is Bone Biologics Corp Common Stock's Enterprise Value?

Bone Biologics Corp Common Stock's Enterprise Value is -$2.5M, based on as-reported figures from SEC (XBRL) filings.

What is Bone Biologics Corp Common Stock's Revenue (TTM)?

Bone Biologics Corp Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Bone Biologics Corp Common Stock's Net Income (TTM)?

Bone Biologics Corp Common Stock's Net Income (TTM) is -$2.9M, based on as-reported figures from SEC (XBRL) filings.

What is Bone Biologics Corp Common Stock's Diluted EPS (TTM)?

Bone Biologics Corp Common Stock's Diluted EPS (TTM) is -1.05, based on as-reported figures from SEC (XBRL) filings.

What is Bone Biologics Corp Common Stock's Net Debt?

Bone Biologics Corp Common Stock's Net Debt is -$4.0M, based on as-reported figures from SEC (XBRL) filings.

Bone Biologics Corp Common Stock (BBLG) Financial Statements

Bone Biologics Corp Common Stock

SIC 3842 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

FIGI BBG007GF2K79

XNAS · usd

0.55▼ 0.00 (-0.56%)

As of 2026-09-10

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.55

Day's Range0.55 – 0.59

52-Week Range0.54 – 2.89

Volume53.6K

Avg Volume564.2K

Share Statistics

Shares Outstanding

Employees2

ExchangeXNAS

Listed2015-11-27

Share count as of August 14, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Bone Biologics Corp Common Stock (BBLG)

What is Bone Biologics Corp Common Stock's Market Cap?: Bone Biologics Corp Common Stock's Market Cap is $1.5M, based on as-reported figures from SEC (XBRL) filings.
What is Bone Biologics Corp Common Stock's Enterprise Value?: Bone Biologics Corp Common Stock's Enterprise Value is -$2.5M, based on as-reported figures from SEC (XBRL) filings.
What is Bone Biologics Corp Common Stock's Revenue (TTM)?: Bone Biologics Corp Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Bone Biologics Corp Common Stock's Net Income (TTM)?: Bone Biologics Corp Common Stock's Net Income (TTM) is -$2.9M, based on as-reported figures from SEC (XBRL) filings.
What is Bone Biologics Corp Common Stock's Diluted EPS (TTM)?: Bone Biologics Corp Common Stock's Diluted EPS (TTM) is -1.05, based on as-reported figures from SEC (XBRL) filings.
What is Bone Biologics Corp Common Stock's Net Debt?: Bone Biologics Corp Common Stock's Net Debt is -$4.0M, based on as-reported figures from SEC (XBRL) filings.